Medicago Company
Medicago is a biotechnology company focused on the research, development, production, and commercialization of vaccines in Canada.
Medicago is developing drug candidates against COVID-19 after having produced Virus-Like Particles (VLP) of the coronavirus. The company has formed a collaboration with Laval University’s Infectious Disease Research Centre to develop antibodies against SARS-CoV-2.
The company’s research activities are being partly funded by the Canadian Institutes for Health Research (CIHR).
Medicago is developing drug candidates against COVID-19 after having produced Virus-Like Particles (VLP) of the coronavirus. The company has formed a collaboration with Laval University’s Infectious Disease Research Centre to develop antibodies against SARS-CoV-2.
The company’s research activities are being partly funded by the Canadian Institutes for Health Research (CIHR).
Technology:
COVID
Industry:
Vaccine/Drug
Headquarters:
Canada
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership